pifithrin has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dexpramipexole is a BTZ structural analog of riluzole and was a great hope for the treatment of ALS." | 6.66 | From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies. ( Desaphy, JF; Lentini, G; Majoral, JP; Mignani, S, 2020) |
| "Dexpramipexole is a BTZ structural analog of riluzole and was a great hope for the treatment of ALS." | 2.66 | From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies. ( Desaphy, JF; Lentini, G; Majoral, JP; Mignani, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mignani, S | 1 |
| Majoral, JP | 1 |
| Desaphy, JF | 1 |
| Lentini, G | 1 |
| Eve, DJ | 1 |
| Dennis, JS | 1 |
| Citron, BA | 1 |
1 review available for pifithrin and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies.
Topics: Amyotrophic Lateral Sclerosis; Animals; Benzothiazoles; Clinical Trials as Topic; Drug Approval; Dru | 2020 |
1 other study available for pifithrin and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Transcription factor p53 in degenerating spinal cords.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Behavior, Animal; Benzothiazoles; Case-Control | 2007 |